TVTX logo

Travere Therapeutics, Inc. (TVTX) return on equity

annual ROE:

-246.75%+62.15%(+20.12%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TVTX annual return on equity is -246.75%, with the most recent change of +62.15% (+20.12%) on December 31, 2024.
  • During the last 3 years, TVTX annual ROE has fallen by -176.58% (-251.65%).
  • TVTX annual ROE is now -127.71% below its all-time high of 890.42%, reached on December 1, 2012.

Performance

TVTX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXprofitability metrics

quarterly ROE:

-772.82%-23.15%(-3.09%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TVTX quarterly return on equity is -772.82%, with the most recent change of -23.15% (-3.09%) on June 30, 2025.
  • Over the past year, TVTX quarterly ROE has dropped by -493.45% (-176.63%).
  • TVTX quarterly ROE is now -173.03% below its all-time high of 1058.19%, reached on March 31, 2013.

Performance

TVTX quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

TVTX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+20.1%-176.6%
3 y3 years-251.7%-777.3%
5 y5 years-354.5%-2064.8%

TVTX ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-251.7%+20.1%-777.3%at low
5 y5-year-354.5%+20.1%-2499.5%at low
alltimeall time-127.7%+20.1%-173.0%at low

TVTX ROE History

DateAnnualQuarterly
Jun 2025
-
-772.82%(+3.1%)
Mar 2025
-
-749.67%(+49.0%)
Dec 2024
-246.75%(-20.1%)
-503.11%(+55.5%)
Sep 2024
-
-323.50%(+15.8%)
Jun 2024
-
-279.37%(+20.3%)
Mar 2024
-
-232.15%(+6.9%)
Dec 2023
-308.90%(+60.7%)
-217.13%(-11.4%)
Sep 2023
-
-244.93%(-15.7%)
Jun 2023
-
-290.41%(+21.6%)
Mar 2023
-
-238.91%(+23.8%)
Dec 2022
-192.18%(+173.9%)
-192.91%(+48.9%)
Sep 2022
-
-129.60%(+47.1%)
Jun 2022
-
-88.09%(+31.8%)
Mar 2022
-
-66.84%(+12.5%)
Dec 2021
-70.17%(-10.5%)
-59.41%(-28.0%)
Sep 2021
-
-82.56%(+6.3%)
Jun 2021
-
-77.66%(-1.6%)
Mar 2021
-
-78.93%(+19.1%)
Dec 2020
-78.37%(+44.4%)
-66.28%(+122.9%)
Sep 2020
-
-29.73%(-16.7%)
Jun 2020
-
-35.70%(-14.3%)
Mar 2020
-
-41.67%(-23.3%)
Dec 2019
-54.29%(+61.6%)
-54.30%(+27.0%)
Sep 2019
-
-42.74%(-10.2%)
Jun 2019
-
-47.59%(+14.8%)
Mar 2019
-
-41.47%(+22.6%)
Dec 2018
-33.59%(+69.0%)
-33.82%(-9.8%)
Sep 2018
-
-37.51%(+46.0%)
Jun 2018
-
-25.70%(+14.6%)
Mar 2018
-
-22.43%(+12.8%)
Dec 2017
-19.88%
-19.88%(+18.9%)
Sep 2017
-
-16.72%(-27.1%)
Jun 2017
-
-22.94%(+1.3%)
DateAnnualQuarterly
Mar 2017
-
-22.65%(+46.5%)
Dec 2016
-15.76%(-117.7%)
-15.46%(+13.4%)
Sep 2016
-
-13.63%(-137.1%)
Jun 2016
-
36.69%(+1.6%)
Mar 2016
-
36.11%(-46.2%)
Dec 2015
89.25%(-70.0%)
67.14%(-16.6%)
Sep 2015
-
80.54%(-227.6%)
Jun 2015
-
-63.11%(+2355.6%)
Mar 2015
-
-2.57%(-100.5%)
Dec 2014
297.81%(+69.2%)
541.69%(-8.0%)
Sep 2014
-
589.10%(+2.6%)
Jun 2014
-
574.37%(+0.1%)
Mar 2014
-
573.53%(+59.0%)
Dec 2013
176.06%(-80.2%)
360.82%(-63.1%)
Sep 2013
-
976.91%(+22.4%)
Jun 2013
-
797.87%(-24.6%)
Mar 2013
-
1058.19%(+18.9%)
Dec 2012
890.42%(+2234.6%)
890.11%(+3622.8%)
Nov 2011
-
23.91%(-14.0%)
Aug 2011
-
27.81%(-17.3%)
May 2011
-
33.61%(-16.4%)
Feb 2011
38.14%(-33.0%)
40.19%(-15.5%)
Nov 2010
-
47.57%(-9.6%)
Aug 2010
-
52.60%(-7.7%)
May 2010
-
56.96%(-11.2%)
Feb 2010
56.91%(+3.6%)
64.17%(-11.1%)
Nov 2009
-
72.15%(-2.6%)
Aug 2009
-
74.06%(+24.8%)
May 2009
-
59.36%(+34.5%)
Feb 2009
54.95%(-45.1%)
44.12%(+81.8%)
Nov 2008
-
24.27%(+95.7%)
Aug 2008
-
12.40%(+91.1%)
May 2008
-
6.49%
Feb 2008
100.00%
-

FAQ

  • What is Travere Therapeutics, Inc. annual return on equity?
  • What is the all time high annual ROE for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual ROE year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly return on equity?
  • What is the all time high quarterly ROE for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly ROE year-on-year change?

What is Travere Therapeutics, Inc. annual return on equity?

The current annual ROE of TVTX is -246.75%

What is the all time high annual ROE for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual return on equity is 890.42%

What is Travere Therapeutics, Inc. annual ROE year-on-year change?

Over the past year, TVTX annual return on equity has changed by +62.15% (+20.12%)

What is Travere Therapeutics, Inc. quarterly return on equity?

The current quarterly ROE of TVTX is -772.82%

What is the all time high quarterly ROE for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly return on equity is 1058.19%

What is Travere Therapeutics, Inc. quarterly ROE year-on-year change?

Over the past year, TVTX quarterly return on equity has changed by -493.45% (-176.63%)
On this page